Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nutriband Inc WT (NTRBW)

Nutriband Inc WT (NTRBW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 2,090 K
  • Annual Income, $ -5,490 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/10/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7500 +100.00%
on 11/15/24
1.9400 -22.68%
on 11/20/24
+0.3500 (+30.43%)
since 10/21/24
3-Month
0.7500 +100.00%
on 11/15/24
2.0000 -25.00%
on 10/14/24
+0.4000 (+36.36%)
since 08/21/24
52-Week
0.1885 +695.76%
on 03/13/24
3.4400 -56.40%
on 07/25/24
+0.9530 (+174.22%)
since 11/21/23

Most Recent Stories

More News
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse

EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:TEVA),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AMRX) EQNX::TICKER_END

NTRB : 4.81 (-2.63%)
NTRBW : 1.5000 (-16.67%)
LLY : 748.01 (-0.25%)
NVS : 104.28 (+0.41%)
TEVA : 17.12 (+0.23%)
AMRX : 8.39 (+0.84%)
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse

NTRB : 4.81 (-2.63%)
NTRBW : 1.5000 (-16.67%)
LLY : 748.01 (-0.25%)
NVS : 104.28 (+0.41%)
TEVA : 17.12 (+0.23%)
AMRX : 8.39 (+0.84%)
NUTRIBAND RECEIVES CHINA PATENT NOTICE OF ALLOWANCE FOR ITS AVERSAâ„¢ ABUSE DETERRENT TRANSDERMAL TECHNOLOGY

Notice of Allowance received from Chinese National Intellectual Property Administration (CNIPA) for a patent application covering its Nutriband AVERSA™ abuse deterrent transdermal technology   Nutriband...

NTRB : 4.81 (-2.63%)
NTRBW : 1.5000 (-16.67%)
Nutriband (NASDAQ: NTRB) Engages IBN for Corporate Communications Expertise

Nutriband (NASDAQ: NTRB, NTRBW), a pharmaceutical company with a special focus on transdermal technologies, today announced that it has selected IBN , a multifaceted financial news and publishing company...

NTRB : 4.81 (-2.63%)
NTRBW : 1.5000 (-16.67%)
Nutriband (NASDAQ: NTRB) Closes $8.4M Private Placement

Nutriband (NASDAQ: NTRB, NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has closed an $8.4 million private placement to fund the...

NTRB : 4.81 (-2.63%)
NTRBW : 1.5000 (-16.67%)
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise

/PRNewswire/ -- The demand for abuse deterrent formulation technology is projected to grow due to growing misuse of drugs among the people. Growing demand for...

NTRBW : 1.5000 (-16.67%)
CYBN : 9.82 (-3.35%)
NTRB : 4.81 (-2.63%)
CMND : 1.3300 (-0.75%)
MNMD : 7.56 (+6.63%)
LLY : 748.01 (-0.25%)
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise

EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:CMND),(NASDAQ:MNMD),(NYSE:CYBN),(NYSE:LLY) EQNX::TICKER_END

NTRB : 4.81 (-2.63%)
NTRBW : 1.5000 (-16.67%)
CMND : 1.3300 (-0.75%)
MNMD : 7.56 (+6.63%)
CYBN : 9.82 (-3.35%)
LLY : 748.01 (-0.25%)
Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology

Patent issuance expands U.S. patent portfolio for AVERSA™ transdermal abuse deterrent technology   Orlando, FL – September 20, 2023 – Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a developer of...

NTRB : 4.81 (-2.63%)
NTRBW : 1.5000 (-16.67%)
Nutriband Inc. Announces Seven-for-Six Forward Stock Split

ORLANDO, FL / ACCESSWIRE / July 27, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) ("Nutriband" or the "Company") announced today that its Board of Directors has approved and declared a 7:6 forward...

NTRB : 4.81 (-2.63%)
NTRBW : 1.5000 (-16.67%)
1.2M Shares of Nutriband Inc. to be Cancelled from Total Outstanding Shares Following Final Court Judgment in Favor of the Company

ORLANDO, FL / ACCESSWIRE / July 26, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that it has received the Final Judgment in favor of the company, effectively allowing the company to...

NTRB : 4.81 (-2.63%)
NTRBW : 1.5000 (-16.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar